Article
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
British journal of cancer - 14 Sept 2001
Iacopetta B, Grieu F, Joseph D, Elsaleh H
Abstract excerpt
High levels of thymidylate synthase (TS) expression have been associated with poor survival of colorectal cancer (CRC) patients to 5-fluorouracil (5-FU)-based chemotherapy. Recent evidence suggests that a polymorphism within the enhancer region of the TS gene promoter can influence TS expression, with the triple repeat homozygote (3R/3R) being associated with significantly higher tumour TS levels than either the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
